Tepezza and Hearing Loss
In January 2020, the U.S. Food and Drug Administration approved Tepezza, manufactured by Horizon Pharmaceuticals, to treat thyroid eye disease. TED inflames the eye muscles, eyelids, tear glands and fatty tissues behind the eye, which pushes the eyes forward causing bulging (known as proptosis) and may cause double vision. The signs and symptoms of TED … Continued